Avalon Ventures
Avalon Ventures is an early stage venture capital fund focused on information technology and life sciences.
Business Model:
Revenue: $6.7M
Employees: 2-10
Rankings
Detailed Avalon Ventures Information
Geographic Data
Address: 1134 Kline Street
City: La Jolla
State: CA
Zip: 92037
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$117M
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
4,012,738Website Global Rank
2,977Website Monthly Traffic
Twitter Followers
Description
Avalon’s long-standing and successful focus has been on seed and early stage companies, including many it formed in the life science and information technology sectors. We believe this is the most challenging and rewarding period of company creation – we are former entrepreneurs driven by passionate people pursuing disruptive ideas in ever changing market environments.
Contact Phone:
+18583482180
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2010 | Standing Cloud | Series B | 3M |
| 10/2007 | Awarepoint | Series C | 3M |
| 11/2017 | ScoreStream | Series A | 0 |
| 3/2011 | Tapad | Angel Round | 0 |
| 3/2006 | Awarepoint | Series A | 4M |
| 9/2014 | Avelas Biosciences | Series B | 7.4M |
| 1/2014 | Avelas Biosciences | Series B | 6.8M |
| 1/2009 | Pictela | Series A | 1.3M |
| 7/2012 | Shelby.tv | Series A | 2.2M |
| 11/2006 | Vocera Communications | Series F | 7M |
| 10/2004 | Vocera Communications | Venture Round | 6M |
| 7/2015 | AeroFS | Series B | 10M |
| 12/2011 | Cloudant | Venture Round | 2.1M |
| 4/2013 | Indix | Series A | 6M |
| 2/2005 | Cambrios Technologies | Series B | 12M |
| 4/2007 | Cambrios Technologies | Series C | 18.5M |
| 11/2009 | Cambrios Technologies | Series D | 14.5M |
| 12/2013 | Simulmedia | Series D | 25M |
| 10/2014 | Empyr | Venture Round | 11M |
| 1/2015 | Primer | Venture Round | - |
| 8/2015 | Skycatch | Series B | 0 |
| 10/2014 | MOGL | Venture Round | 11M |
| 3/2021 | Janux Therapeutics | Series A | 0 |
| 9/2013 | Otonomy | Series C | 45.9M |
| 8/2015 | MOGL | Venture Round | 7.9M |
| 7/2012 | Byliner | Series A | - |
| 8/2016 | Avelas Biosciences | Series C | 0 |
| 6/2015 | Pronoun | Series B | 3.5M |
| 10/2011 | TwinStrata | Series B | 8M |
| 4/2015 | Cardeas Pharma | Series B | 37.5M |
| 5/2015 | Tapad | Series B | 0 |
| 9/2008 | Afraxis | Series A | 1.5M |
| 12/2017 | Pando | Seed Round | 3.1M |
| 4/2013 | Proximal Data | Series B | 2M |
| 6/2020 | Pando | Series A | 0 |
| 6/2010 | Chartio | Seed Round | 0 |
| 8/2021 | Jnana Therapeutics | Series B | 50M |
| 6/2017 | Talla | Series A | 8.3M |
| 5/2014 | Skycatch | Venture Round | 13.2M |
| 9/2014 | Thyritope Biosciences | Series A | 10M |
| 10/2013 | Redbooth | Series A | 5M |
| 7/2013 | Conjur | Seed Round | - |
| 5/2007 | Intercasting | Series B | 12M |
| 12/2015 | Enlibrium | Series A | 15M |
| 1/2011 | Aratana Therapeutics | Series A | 0 |
| 8/2005 | Intercasting | Series A | 5.5M |
| 3/2013 | Tapad | Series B | 6.5M |
| 10/2009 | JustSpotted | Seed Round | 750k |
| 4/2014 | Synthorx | Series A | 3.1M |
| 11/2012 | Kaltura | Series D | 25M |
| 6/2018 | Memrise | Series B | 15.5M |
| 2/2011 | RQx Pharmaceuticals | Series A | 7M |
| 11/2013 | Sitari Pharmaceuticals | Series A | 10M |
| 9/2014 | Silarus Therapeutics | Series A | 10M |
| 2/2011 | MOGL | Series A | 2.4M |
| 7/2012 | Kinvey | Series A | 5M |
| 3/2008 | Chumby | Series B | 12.5M |
| 6/2015 | Cadherx Therapeutics | Series A | 10M |
| 12/2012 | Avelas Biosciences | Series A | 7.7M |
| 4/2012 | Simulmedia | Series C | 6M |
| 11/2007 | AnaptysBio | Series B | 0 |
| 6/2015 | Indix | Series B | 15M |
| 2/2014 | Sidecar Technologies | Series B | 10M |
| 7/2008 | Zynga | Series B | 25M |
| 5/2015 | BookBub | Series B | 7M |
| 6/2019 | Simulmedia | Series E | 29M |
| 3/2020 | Orion Labs | Series B | 0 |
| 10/2022 | Enlaza Therapeutics | Seed Round | 61M |
| 7/2016 | Synthorx | Series B | 10M |
| 4/2021 | Janux Therapeutics | Series B | 0 |
| 2/2014 | MOGL | Series B | 10.5M |
| 12/2011 | Aratana Therapeutics | Series B | 15M |
| 4/2007 | Syndax Pharmaceuticals | Series A | 40M |
| 3/2010 | Syndax Pharmaceuticals | Series A | 9M |
| 2/2011 | Empyr | Series A | 2.4M |
| 1/2012 | Empyr | Series B | 12M |
| 4/2014 | Otonomy | Series D | 49M |
| 11/2022 | Jnana Therapeutics | Series C | 0 |
| 2/2007 | Inogen | Series D | 22M |
| 8/2015 | Empyr | Venture Round | 7.9M |
| 9/2018 | Joy | Series A | 0 |
| 6/2014 | Tapad | Series B | 0 |
| 2/2008 | Zynga | Series A | 5M |
| 3/2009 | Simulmedia | Series A | 4M |
| 5/2011 | Simulmedia | Series C | 9.3M |
| 4/2010 | Simulmedia | Series B | 8M |
| 12/2017 | Jnana Therapeutics | Series A | 50M |
| 1/2008 | Zynga | Series A | 0 |
| 9/2011 | Techstars | Venture Round | 24M |
| 7/2019 | Node | Venture Round | 0 |
| 8/2005 | Amira Pharmaceuticals | Series A | 3M |
| 4/2015 | ScoreStream | Seed Round | 3M |
| 6/2016 | Node | Seed Round | 7.5M |
| 3/2015 | Nanigans | Series B | 24M |
| 5/2013 | Cloudant | Series B | 12M |
| 4/2010 | RethinkDB | Seed Round | 1.2M |
| 9/2016 | Fortis Therapeutics | Series A | 18M |
| 3/2021 | Fortis Therapeutics | Series A | 0 |
| 9/2009 | Cloudkick | Seed Round | 750k |
| 12/2006 | Chumby | Series A | 5M |
| 12/2014 | Conjur | Venture Round | 2.6M |
| 3/2010 | Ad Summos | Venture Round | 3M |
| 6/2007 | Ortiva Wireless | Series B | 15M |
| 2/2017 | Piper Networks | Venture Round | 5.8M |
| 12/2008 | Cloudant | Series A | 1M |
| 2/1999 | TomoTherapy | Series A | 3M |
| 2/2011 | Kaltura | Series C | 20M |
| 9/2010 | Backupify | Series A | 4.5M |
| 5/2018 | BotChain | Venture Round | 5M |
| 1/2014 | Chartio | Venture Round | 2.2M |
| 9/2021 | Joy | Series A | 0 |
| 3/2007 | Amira Pharmaceuticals | Series B | 25M |
| 4/2013 | Nanigans | Series A | 5.8M |
| 2/2015 | Overlap.cc | Pre Seed Round | - |
| 4/2017 | NanoNets | Seed Round | 1.4M |
| 11/2008 | Zacharon Pharmaceuticals | Series A | 3.5M |
| 1/2012 | MOGL | Series B | 12M |
| 7/2016 | AristaMD | Series A | 11M |
| 1/2013 | LoopIt | Seed Round | - |
| 4/2018 | Synthorx | Series C | 63M |
| 6/2008 | Kaltura | Series B | 21M |
| 4/2003 | Ansata Therapeutics | Series B | 2.5M |
| 11/2007 | BioVex | Series E | 35M |
| 6/2015 | Ankasa Regenerative Therapeutics | Series A | 8.5M |
| 4/2020 | Figg | Funding Round | - |
| 10/2003 | BioVex | Series C | 28.4M |
| 7/2014 | ScoreStream | Convertible Note | 800k |
| 10/2014 | StackIQ | Series B | 6M |
| 7/2006 | AnaptysBio | Series A | 2M |
| 2/1992 | Metra Biosystems | Venture Round | - |
| 5/2009 | E-Band Communications | Series C | - |
| 12/2015 | AlphaSheets | Seed Round | 5.5M |
| 9/2014 | Sidecar Technologies | Series C | 15M |
| 10/2012 | Proximal Data | Series A | 3M |
| 9/2011 | RethinkDB | Series A | 0 |
| 5/2013 | Happy Cloud | Series A | 4.3M |
| 2/2014 | Empyr | Series B | 10.5M |
| 6/2021 | Primer | Series C | 0 |
| 12/2010 | Cloudant | Series A | 1M |
| 6/2006 | Kalon Semiconductor | Series A | 10.9M |
| 7/2012 | Backupify | Series C | 9M |
| 2/2012 | Memrise | Seed Round | 0 |
| 9/2011 | Backupify | Series B | 5M |
| 11/2014 | Redbooth | Series B | 11M |
| 3/2017 | Smyte | Series A | 4M |
| 6/2012 | Cardeas Pharma | Series A | 8.5M |
| 12/2012 | Cheezburger | Venture Round | 5M |
| 2/2013 | Simulmedia | Series C | 5M |
| 1/2015 | Primer | Seed Round | - |
| 1/2014 | Quippi | Venture Round | 2M |
| 11/2012 | Pingup | Series A | 4M |
| 6/2015 | Calporta Therapeutics | Series A | 10M |
| 1/2011 | Cheezburger | Venture Round | 30M |
| 5/2007 | Kaltura | Series A | 2.1M |
| 7/2007 | Awarepoint | Series B | 2M |
| 12/2000 | Ambit Biosciences | Series B | 18.8M |
| 2/2000 | ChoiceSeat technology | Venture Round | 22.4M |
| 11/2006 | Amira Pharmaceuticals | Series A | 4M |
| 3/2018 | Averon | Series A | 11.7M |
| 10/2011 | Chartio | Series A | 3.1M |
| 3/2020 | AristaMD | Series B | 0 |
| 1/2010 | Pictela | Venture Round | 1.5M |
| 10/2017 | Averon | Series A | 8.3M |
| 2/2016 | Orion Labs | Series A | 9M |
| 7/2011 | Shelby.tv | Seed Round | 1.5M |
| 9/2014 | Kinvey | Series B | 10.9M |
| 6/2012 | Awarepoint | Venture Round | 14M |
| 11/2011 | Standing Cloud | Venture Round | 3M |
| 10/2018 | Seva Inc. | Seed Round | 2.4M |
| 12/2008 | Awarepoint | Series D | 13.3M |
| 5/2005 | Ambit Biosciences | Series C | 31M |
| 1/2015 | StackRox | Seed Round | - |
| 5/2014 | BookBub | Series A | 3.8M |
| 6/2010 | Otonomy | Series A | 10M |
| 4/2010 | Cloudkick | Series A | 2M |
| 10/2012 | Selectable Media | Series A | 2M |
| 8/2011 | Nanigans | Series A | 3M |
| 3/2014 | Indix | Series A | 8.5M |
| 11/2008 | Selectable Media | Venture Round | 2.6M |
| 9/2021 | Joy | Series A | 0 |
| 8/2021 | Jnana Therapeutics | Series B | 0 |
| 6/2021 | Primer | Series C | 0 |
| 4/2021 | Janux Therapeutics | Series B | 0 |
| 3/2021 | Fortis Therapeutics | Series A | 0 |
| 3/2021 | Janux Therapeutics | Series A | 0 |
| 6/2020 | Pando | Series A | 0 |
| 4/2020 | Figg | Funding Round | - |
| 3/2020 | AristaMD | Series B | 0 |
| 3/2020 | Orion Labs | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
